Rhumbline Advisers 22nd Century Group, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$0.35 - $0.74 $66,841 - $141,322	-190,976 Reduced 90.97%	18,958 $7,000
Q1 2023 May 11, 2023	BUY	$0.72 - $1.21 $1,480 - $2,487	2,056 Added 0.99%	209,934 $161,000
Q4 2022 Feb 14, 2023	BUY	$0.82 - $1.36 $6,272 - $10,402	7,649 Added 3.82%	207,878 $191,000
Q3 2022 Nov 10, 2022	BUY	$0.91 - $2.27 $9,147 - $22,818	10,052 Added 5.29%	200,229 $186,000
Q2 2022 Aug 11, 2022	BUY	$1.5 - $2.57 $52,231 - $89,489	34,821 Added 22.41%	190,177 $405,000
Q1 2022 May 12, 2022	BUY	$1.99 - $3.0 $82,173 - $123,879	41,293 Added 36.2%	155,356 $360,000
Q4 2021 Feb 10, 2022	SELL	$2.14 - $3.31 $4,898 - $7,576	-2,289 Reduced 1.97%	114,063 $352,000
Q3 2021 Nov 12, 2021	BUY	$2.86 - $4.21 $50,570 - $74,441	17,682 Added 17.92%	116,352 $344,000
Q2 2021 Aug 05, 2021	BUY	$3.21 - $5.62 $316,730 - $554,525	98,670 New	98,670 $457,000
Q2 2020 Aug 13, 2020	SELL	$0.67 - $1.03 $101,182 - $155,548	-151,018 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$0.82 - $2.24 $227 - $622	278 Added 0.18%	151,018 $166,000
Q3 2019 Oct 23, 2019	SELL	$1.36 - $2.4 $1,319 - $2,328	-970 Reduced 0.64%	150,740 $341,000
Q2 2019 Aug 14, 2019	BUY	$1.73 - $2.37 $6,795 - $9,309	3,928 Added 2.66%	151,710 $317,000
Q1 2019 May 01, 2019	BUY	$1.71 - $2.85 $4,705 - $7,843	2,752 Added 1.9%	147,782 $253,000
Q4 2018 Jan 31, 2019	BUY	$2.15 - $3.11 $105,079 - $151,998	48,874 Added 50.83%	145,030 $361,000
Q3 2018 Nov 07, 2018	SELL	$2.28 - $2.93 $8,568 - $11,010	-3,758 Reduced 3.76%	96,156 $270,000
Q2 2018 Aug 06, 2018	BUY	$2.02 - $2.55 $201,826 - $254,780	99,914 New	99,914 $246,000

Others Institutions Holding XXII

# of Institutions

Shares Held

1.27M

Call Options Held

Put Options Held

View Full List

About 22nd Century Group, Inc.

Ticker XXII
Exchange NASDAQ
Sector Consumer Defensive
Industry Tobacco
Shares Outstandng 214,784,992
Market Cap $19.3M
Description
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King n...

More about XXII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account